Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

99 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Protease-Activated Receptor-1 IgG Autoantibodies in Patients with COVID-19.
Reinshagen L, Nageswaran V, Heidecke H, Schulze-Forster K, Wilde AB, Ramezani Rad P, Poller W, Asmus E, Simmons S, Kuebler WM, Witzenrath M, Markó L, Jakobs K, Puccini M, Leistner DM, Rauch-Kröhnert U, Kränkel N, Forslund SK, Landmesser U, Müller DN, Haghikia A. Reinshagen L, et al. Among authors: heidecke h. Thromb Haemost. 2024 Dec;124(12):1164-1166. doi: 10.1055/a-2205-0014. Epub 2023 Nov 6. Thromb Haemost. 2024. PMID: 37931906 No abstract available.
Cross-sectional analysis reveals autoantibody signatures associated with COVID-19 severity.
Baiocchi GC, Vojdani A, Rosenberg AZ, Vojdani E, Halpert G, Ostrinski Y, Zyskind I, Filgueiras IS, Schimke LF, Marques AHC, Giil LM, Lavi YB, Silverberg JI, Zimmerman J, Hill DA, Thornton A, Kim M, De Vito R, Fonseca DLM, Plaça DR, Freire PP, Camara NOS, Calich VLG, Scheibenbogen C, Heidecke H, Lattin MT, Ochs HD, Riemekasten G, Amital H, Shoenfeld Y, Cabral-Marques O. Baiocchi GC, et al. Among authors: heidecke h. J Med Virol. 2023 Feb;95(2):e28538. doi: 10.1002/jmv.28538. J Med Virol. 2023. PMID: 36722456
Increased protease-activated receptor 1 autoantibodies are associated with severe COVID-19.
Tran F, Harris DMM, Scharmacher A, Graßhoff H, Sterner K, Schinke S, Käding N, Humrich JY, Cabral-Marques O, Bernardes JP, Mishra N, Bahmer T, Franzenburg J, Hoyer BF, Glück A, Guggeis M, Ossysek A, Küller A, Frank D, Lange C, Rupp J, Heyckendorf J, Gaede KI, Amital H, Rosenstiel P, Shoenfeld Y, Halpert G, Rosenberg AZ, Schulze-Forster K, Heidecke H, Riemekasten G, Schreiber S. Tran F, et al. Among authors: heidecke h. ERJ Open Res. 2022 Dec 27;8(4):00379-2022. doi: 10.1183/23120541.00379-2022. eCollection 2022 Oct. ERJ Open Res. 2022. PMID: 36575710 Free PMC article.
Autoantibodies against the chemokine receptor 3 predict cardiovascular risk.
Müller FS, Aherrahrou Z, Grasshoff H, Heidorn MW, Humrich JY, Johanson L, Aherrahrou R, Reinberger T, Schulz A, Ten Cate V, Robles AP, Koeck T, Rapp S, Lange T, Brachaczek L, Luebber F, Erdmann J, Heidecke H, Schulze-Forster K, Dechend R, Lackner KJ, Pfeiffer N, Ghaemi Kerahrodi J, Tüscher O, Schwarting A, Strauch K, Münzel T, Prochaska JH, Riemekasten G, Wild PS. Müller FS, et al. Among authors: heidecke h. Eur Heart J. 2023 Dec 14;44(47):4935-4949. doi: 10.1093/eurheartj/ehad666. Eur Heart J. 2023. PMID: 37941454 Free PMC article.
Low avidity circulating SARS-CoV-2 reactive CD8+ T cells with proinflammatory TEMRA phenotype are associated with post-acute sequelae of COVID-19.
Paniskaki K, Konik MJ, Anft M, Heidecke H, Meister TL, Pfaender S, Krawczyk A, Zettler M, Jäger J, Gaeckler A, Dolff S, Westhoff TH, Rohn H, Stervbo U, Scheibenbogen C, Witzke O, Babel N. Paniskaki K, et al. Among authors: heidecke h. Front Microbiol. 2023 Jun 2;14:1196721. doi: 10.3389/fmicb.2023.1196721. eCollection 2023. Front Microbiol. 2023. PMID: 37333646 Free PMC article.
Autoantibodies targeting G protein-coupled receptors: An evolving history in autoimmunity. Report of the 4th international symposium.
Cabral-Marques O, Moll G, Catar R, Preuß B, Bankamp L, Pecher AC, Henes J, Klein R, Kamalanathan AS, Akbarzadeh R, van Oostveen W, Hohberger B, Endres M, Koolmoes B, Levarht N, Postma R, van Duinen V, van Zonneveld AJ, de Vries-Bouwstra J, Fehres C, Tran F, do Vale FYN, da Silva Souza KB, Filgueiras IS, Schimke LF, Baiocchi GC, de Miranda GC, da Fonseca DLM, Freire PP, Hackel AM, Grasshoff H, Stähle A, Müller A, Dechend R, Yu X, Petersen F, Sotzny F, Sakmar TP, Ochs HD, Schulze-Forster K, Heidecke H, Scheibenbogen C, Shoenfeld Y, Riemekasten G. Cabral-Marques O, et al. Among authors: heidecke h. Autoimmun Rev. 2023 May;22(5):103310. doi: 10.1016/j.autrev.2023.103310. Epub 2023 Mar 10. Autoimmun Rev. 2023. PMID: 36906052 Review.
Nailfold Videocapillaroscopy for Non-Invasive Assessment of Microcirculation and Prognostic Correlation with Endothelial Dysfunction, Cardiovascular Risk Factors, and Non-HLA Antibodies in Heart Transplant Recipients: A Pilot Study.
Sikorska D, Kamińska D, Catar R, Wu D, Zhao H, Wang P, Kamhieh-Milz J, Banasik M, Kusztal M, Cielecka M, Zakliczyński M, Rutkowski R, Korybalska K, Heidecke H, Moll G, Samborski W. Sikorska D, et al. Among authors: heidecke h. J Clin Med. 2023 Mar 16;12(6):2302. doi: 10.3390/jcm12062302. J Clin Med. 2023. PMID: 36983302 Free PMC article.
Intensive receptor blockade and plasma exchange to treat refractory scleroderma renal crisis in patients with agonistic autoantibodies targeting the angiotensin II type 1 and endothelin-1 type A receptors.
Hegner B, Callaghan J, Schindler R, Heidecke H, Riemekasten G, Philippe A, Catar R. Hegner B, et al. Among authors: heidecke h. J Scleroderma Relat Disord. 2024 Feb;9(1):NP1-NP6. doi: 10.1177/23971983231168193. Epub 2023 Apr 30. J Scleroderma Relat Disord. 2024. PMID: 38333524
99 results